Literature DB >> 1671676

Resistance to antimitotic drugs in Chinese hamster ovary cells correlates with changes in the level of polymerized tubulin.

A M Minotti1, S B Barlow, F Cabral.   

Abstract

A sensitive and reproducible method to measure relative levels of polymerized and soluble tubulin in cells has been developed. This method involves metabolically labeling cells with radioactive amino acids followed by lysis in a microtubule-stabilizing buffer, centrifugation to separate soluble from polymerized tubulin, resolution of the proteins in each fraction by two-dimensional gel electrophoresis, and quantitation of the tubulin by liquid scintillation counting of spots excised from the gel. Several buffers were evaluated for their reproducibility and efficacy in preserving the state of in vivo microtubule assembly at the time of cell lysis, and the ability of the technique to measure drug-induced changes in tubulin polymerization was determined. Results using this method indicate that Chinese hamster ovary cells maintain approximately 40% of the cellular tubulin in an assembled form. Dose-dependent decreases in tubulin polymerization could be measured in Colcemid-treated cells, while dose-dependent increases in assembly were measured in taxol-treated cells. The results with taxol indicate that, following the increase in microtubule polymerization, there is a time-dependent bundling of microtubules that occurs without further increases in the extent of tubulin assembly. Examination of drug-resistant Chinese hamster ovary cells reveals that Colcemid-resistant mutants maintain more tubulin in the polymerized state (approximately 50%), while taxol-resistant mutants maintain less assembled tubulin (about 28%). Similar changes occur regardless of whether the mutant cells have an alteration in alpha- or in beta-tubulin. A model to explain these results is discussed.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1671676

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  70 in total

1.  Op18/stathmin mediates multiple region-specific tubulin and microtubule-regulating activities.

Authors:  N Larsson; B Segerman; B Howell; K Fridell; L Cassimeris; M Gullberg
Journal:  J Cell Biol       Date:  1999-09-20       Impact factor: 10.539

Review 2.  Overcoming drug resistance in ovarian carcinoma.

Authors:  P M Fracasso
Journal:  Curr Oncol Rep       Date:  2001-01       Impact factor: 5.075

3.  Taxol-resistant epithelial ovarian tumors are associated with altered expression of specific beta-tubulin isotypes.

Authors:  M Kavallaris; D Y Kuo; C A Burkhart; D L Regl; M D Norris; M Haber; S B Horwitz
Journal:  J Clin Invest       Date:  1997-09-01       Impact factor: 14.808

4.  Phosphorylation-dependent localization of microtubule-associated protein MAP2c to the actin cytoskeleton.

Authors:  R S Ozer; S Halpain
Journal:  Mol Biol Cell       Date:  2000-10       Impact factor: 4.138

5.  Paclitaxel-dependent cell lines reveal a novel drug activity.

Authors:  Anutosh Ganguly; Hailing Yang; Fernando Cabral
Journal:  Mol Cancer Ther       Date:  2010-10-26       Impact factor: 6.261

Review 6.  Mechanisms of Taxol resistance related to microtubules.

Authors:  George A Orr; Pascal Verdier-Pinard; Hayley McDaid; Susan Band Horwitz
Journal:  Oncogene       Date:  2003-10-20       Impact factor: 9.867

7.  Dissociation of the tubulin dimer is extremely slow, thermodynamically very unfavorable, and reversible in the absence of an energy source.

Authors:  Michael Caplow; Lanette Fee
Journal:  Mol Biol Cell       Date:  2002-06       Impact factor: 4.138

8.  A ubiquitous beta-tubulin disrupts microtubule assembly and inhibits cell proliferation.

Authors:  Rajat Bhattacharya; Fernando Cabral
Journal:  Mol Biol Cell       Date:  2004-04-30       Impact factor: 4.138

9.  Inhibition of cell migration and cell division correlates with distinct effects of microtubule inhibiting drugs.

Authors:  Hailing Yang; Anutosh Ganguly; Fernando Cabral
Journal:  J Biol Chem       Date:  2010-08-09       Impact factor: 5.157

10.  TBCE Mutations Cause Early-Onset Progressive Encephalopathy with Distal Spinal Muscular Atrophy.

Authors:  Antonella Sferra; Gilbert Baillat; Teresa Rizza; Sabina Barresi; Elisabetta Flex; Giorgio Tasca; Adele D'Amico; Emanuele Bellacchio; Andrea Ciolfi; Viviana Caputo; Serena Cecchetti; Annalaura Torella; Ginevra Zanni; Daria Diodato; Emanuela Piermarini; Marcello Niceta; Antonietta Coppola; Enrico Tedeschi; Diego Martinelli; Carlo Dionisi-Vici; Vincenzo Nigro; Bruno Dallapiccola; Claudia Compagnucci; Marco Tartaglia; Georg Haase; Enrico Bertini
Journal:  Am J Hum Genet       Date:  2016-09-22       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.